Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection Fraction
Recruiting
Early Phase 1
Interventional Study
Heart Failure With Preserved Ejection Fraction (HFPEF)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 85
- Sex
- Any
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 70 (estimated)
- Sponsor
- University of Florida · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Subjects undergo a gadolinium-based CMR followed by an iron infusion and then a repeat CMR in 72 hours
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* HFpEF
Exclusion Criteria:
* Renal insufficiency
Contacts